Amedisys (NASDAQ:AMED) earlier ticked down 0.2% on a report that the Dept. of Justice has initially rejected the proposed ...

The U.S. Department of Justice (DOJ) has reportedly rejected Amedisys’ (Nasdaq: AMED) and UnitedHealth Group’s (NYSE: UNH) attempt to divest assets, a ...

The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the Department of Justice sued to block the deal last year. Amedisys delivers ...

For those who have been following the U.S. Department of Justice’s (DOJ) legal battle against UnitedHealth Group (NYSE: UNH) and Amedisys Inc. (NASDAQ: ...

Amedisys (AMED) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives ...

Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.

(2) Adjusted EBITDA is defined as net income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain items as ...

BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025. Three-Month Periods Ended ...

AMEDISYS ($AMED) posted quarterly earnings results on Wednesday, April 23rd. The company reported earnings of $1.25 per share, beating estimates of $1.11 by $0.14 ...

Amedisys (NASDAQ:AMED) earlier ticked down 0.2% on a report that the Dept. of Justice has initially rejected the proposed divestiture buyers for its planned sale to UnitedHealth (NYSE:UNH).